Results 11 to 20 of about 159 (89)

A systematic review of fluralaner as a treatment for ectoparasitic infections in mammalian species [PDF]

open access: yesPeerJ
Fluralaner (Bravecto™) is a novel isoxazoline ectoparasiticide used for controlling ectoparasites of domestic mammals and is increasingly being used on wildlife. The aim of this systematic review was to evaluate the efficacy, pharmacokinetics, and safety
Yuanting Jiang, Julie M. Old
doaj   +3 more sources

Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats [PDF]

open access: yesParasites & Vectors, 2018
Background Fluralaner provides efficacy against feline ectoparasites following topical administration. Moxidectin is routinely used to treat gastrointestinal nematode infections and prevent heartworm disease caused by Dirofilaria immitis. Praziquantel is
Feli M. Walther   +2 more
doaj   +2 more sources

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs [PDF]

open access: yesParasites & Vectors, 2014
Background Fluralaner, a new molecular entity of the isoxazoline class, has potent insecticidal and acaricidal activity and can be safely administered orally to dogs.
Nadja Rohdich   +2 more
doaj   +2 more sources

Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin) [PDF]

open access: yesParasites & Vectors, 2014
Background Bravecto™ (fluralaner; MSD Animal Health) is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose.
Feli M Walther   +4 more
doaj   +2 more sources

Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration. [PDF]

open access: yesParasit Vectors, 2016
BACKGROUND: Bravecto™ Chewable Tablets for Dogs, containing fluralaner as active ingredient, is an innovative treatment for flea and tick infestations that provides safe, rapid and long acting efficacy after a single oral administration in dogs ...
Kilp S, Ramirez D, Allan MJ, Roepke RK.
europepmc   +3 more sources

Fluralaner, a novel isoxazoline, prevents flea (Ctenocephalides felis) reproduction in vitro and in a simulated home environment [PDF]

open access: yesParasites & Vectors, 2014
Background Fluralaner, a novel isoxazoline, has both acaricidal and insecticidal activity through potent blockage of GABA- and L-glutamate-gated chloride channels.
Heike Williams   +4 more
doaj   +2 more sources

A comparative laboratory trial evaluating the immediate efficacy of fluralaner, afoxolaner, sarolaner and imidacloprid + permethrin against adult Rhipicephalus sanguineus (sensu lato) ticks attached to dogs [PDF]

open access: yes, 2012
Variational methods are used for targeting specific correlation effects by tailoring the configuration space. Independent sets of correlation orbitals, embedded in partitioned correlation functions (PCFs), are produced from multiconfiguration Hartree-
Froese Fischer, Charlotte   +5 more
core   +2 more sources

Midgut proteome of an argasid tick, Ornithodoros erraticus: a comparison between unfed and engorged females [PDF]

open access: yes, 2007
16 páginas, 5 figuras y 2 tablas. -- Agradecimientos: Asistencia técnica de Rocío Vizcaíno Marín y María González Sánchez, del Instituto de Recursos Naturales y Agrobiología de Salamanca (IRNASA-CSIC) y de la Dra.
Oleaga, Ana   +3 more
core   +2 more sources

Treatment of dogs with fluralaner reduced pyrethroid-resistant Triatoma infestans abundance, Trypanosoma cruzi infection and human-triatomine contact in the Argentine Chaco [PDF]

open access: yes, 2022
Background: Triatomine elimination efforts and the interruption of domestic transmission of Trypanosoma cruzi are hampered by pyrethroid resistance. Fluralaner, a long-lasting ectoparasiticide administered to dogs, substantially reduced site infestation ...
Alvedro, Alejandra   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy